Adalimumab vs Piflufolastat F18

## Adalimumab vs Piflufolastat F18: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Piflufolastat F18**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Piflufolastat F18 — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Piflufolastat F18 — Small molecule.